EVALUATING THE EFFECTIVENESS OF CITOFLAVINI IN PATIENTS WITH CHRONIC HEART FAILURE
There are a certain success regarding CHF patients is therapy but death rate is still high. That is why the matter of metabolic therapy practicability and their influence mechanisms for CHF patients with ischemic disease is still of current interest. The aim of the work is results of treatment of citoflavini in patients with Chronic Heart Failure. Implementation of citoflavini in accordance with standard CHF therapy for ischemic disease patients was accompanied by the improvement of clinical state, functional status. Citoflavini therapy didn’t lead to the development of a serious adverse reaction.